Serving the growing biotechnology community

The Latest News from BioAgilytix

5 November, 2019

Triangle-based BioAgilytix Acquires Cambridge CRO, Plans Hiring, More Acquisitions

North Carolina Biotechnology Center covers BioAgilytix’s recent acquisition of Cambridge Biomedical in the world’s major biotech center, as well as its plans for future hiring and acquisitions.

Read More

4 November, 2019

Durham-based BioAgilytix acquires Massachusetts biomedical firm

The WRAL TechWire covers BioAgilytix’s recent acquisition of Massachusetts-based Cambridge Biomedical, and how it plans to unite two science-led teams to expand its footprint in this area of biotech innovation.

Read More

4 November, 2019

BioAgilytix Announces Acquisition of Boston-Based Clinical Research Organization Cambridge Biomedical

Cambridge Biomedical, a contract research organization based in the Cambridge area of Massachusetts, also specializes in large molecule bioanalysis. The transaction expands BioAgilytix’s global footprint into the heart of the world’s major biotech center, and adds further capacity by joining Cambridge Biomedical’s CLIA-certified, CAP-accredited, and GLP-compliant facility with its GxP laboratories in Durham, North Carolina and Hamburg, Germany.

Read More

22 October, 2019

BioAgilytix Receives Certificate of Registration from CLIA

BioAgilytix has received its Certificate of Registration from the Clinical Laboratory Improvement Amendments (CLIA) program regulated by the Centers for Medicare & Medicaid Services (CMS) for its U.S. facility in Durham, NC. The CLIA certificate confirms that BioAgilytix is now able to perform lab-developed tests in the diagnostic immunology specialty that are deemed “high complexity” and subject to CLIA oversight.

Read More

14 October, 2019

TBJ reveals the 2019 Fast 50 Awards winners

The Triangle Business Journal is unveiling the 2019 Fast 50 Award winners (BioAgilytix featured).

Read More

14 October, 2019

BioAgilytix Named a Triangle Business Journal Fast 50 Winner for 2019

BioAgilytix has been named by Triangle Business Journal as a Fast 50 Award winner for 2019, marking the seventh time the organization has been recognized as one of the fastest growing privately held companies in the Triangle Park area.

Read More

25 September, 2019

Webinar Q&A follow up – exploratory biomarker testing: to qualify or validate the assay?

Afshin Safavi, PhD (Founder and Board Member, BioAgilytix, NC, USA) share his responses to the questions posed by our audience during the live webinar event, “Exploratory biomarker testing: to qualify…

Read More

15 August, 2019

Thomas Zajkowski Joins BioAgilytix Leadership Team as Chief Financial Officer

Mr. Zajkowski brings more than 25 years of experience managing finance functions in private equity-sponsored and publicly-traded companies, including multiple healthcare and life sciences organizations.

Read More

14 August, 2019

BioAgilytix Named to Inc. Magazine’s Inc. 5000 List of Fastest-Growing Private U.S. Companies for Sixth Time

BioAgilytix has been named to Inc. Magazine’s Inc. 5000 list of the fastest-growing private companies in America for 2019: its sixth appearance on the list in the last seven years.

Read More